trial · primary record
pUMVC3-hIGFBP-2 Multi-epitope Plasmid DNA Vaccine
Fallopian Tube Carcinoma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 26 |
| Primary completion | 2028-09-30 |
| Primary endpoint | Progression free survival |
| Registry ID | NCT07495124 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:09.617Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07495124
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.